Pain-relieving prospects for adenosine receptors and ectonucleotidases.
about
Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activityPain and Poppies: The Good, the Bad, and the Ugly of Opioid AnalgesicsAdenosine-associated delivery systemsThe Role of Caffeine in Pain Management: A Brief Literature ReviewCellular function and molecular structure of ecto-nucleotidases.Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1PAPupuncture has localized and long-lasting antinociceptive effects in mouse models of acute and chronic painTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine system.Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.Modulation of extracellular ATP content of mast cells and DRG neurons by irradiation: studies on underlying mechanism of low-level-laser therapy.Evidence for A1 and A 3 receptors mediating adenosine-induced intracellular calcium release in the dorsal root ganglion neurons by using confocal microscopy imaging.Deletion of ENTPD3 does not impair nucleotide hydrolysis in primary somatosensory neurons or spinal cord.Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic painPAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosineAMP is an adenosine A1 receptor agonistMedicinal chemistry of adenosine, P2Y and P2X receptors.Controlling murine and rat chronic pain through A3 adenosine receptor activationEctonucleotidases in solid organ and allogeneic hematopoietic cell transplantationCurrent challenges in translational pain research.Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.Traditional acupuncture triggers a local increase in adenosine in human subjects.Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord.Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.Adenosine-A1 receptor agonist induced hyperalgesic priming type II.Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation.Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain.Inflammation, pain, and pressure--purinergic signaling in oral tissues.Adenosine A1 modulators: a patent update (2008 to present).Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects.Acupuncture-Induced Analgesia: A Neurobiological Basis in Purinergic Signaling.Safety issues of compounds acting on adenosinergic signalling.Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System.Melatonin receptor deficiency decreases and temporally shifts ecto-5'-nucleotidase mRNA levels in mouse prosencephalon.8-BuS-ATP derivatives as specific NTPDase1 inhibitors.Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia.South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.
P2860
Q24306734-698F043C-8DF6-46C2-BC8C-8F82127896CCQ26782928-B5DD39E6-403C-49BA-BEE0-6734707E409CQ26785351-A9521D05-256F-43C8-923C-4A24EA6D769AQ28069184-04151CE3-B32C-4B21-A2FE-09B3AEC588C9Q34031794-45237F4C-7CA7-49FD-BDE2-0D71CA0C4FEEQ34087391-B7C60D2C-E528-42B5-BC3C-BAF1575B3BD4Q34270181-F65A4BB2-280A-4866-92C6-3531F1464393Q34376548-1A27D3BB-64FB-47D5-B2BD-649C882EB2FAQ34500222-FF051913-C236-4366-96DD-1915A7FB6BDBQ34680354-6DD3E2D0-4FF2-4AE2-BBFF-3EE20D20A472Q34701441-991A1297-1FAD-43A3-90DC-D9A02D82E2C3Q34765028-F62FBC96-1D5B-46F2-B73F-AC754C327145Q34842406-D913DE90-4001-4818-A49E-715698F1EE78Q35066805-C7D06BAF-50B3-49AB-89C2-F7997ED201D1Q35071671-B653B5A9-894C-4A18-B87C-775EF098CFD1Q35086776-86DF9BC1-A4BD-4819-A6B5-7A956C653BF7Q35423661-4D12CBED-3FCC-4CBD-8CF2-07AC7E8D9287Q35533525-A09B6E69-DC84-4C76-A57F-A14390E1C50CQ35773917-9978CEFD-B6E7-47B8-8CD4-FE22B5B76C5EQ35873582-A4697AC8-1A85-4FD7-8E65-497062A63BAEQ35913037-B54E8E0D-9423-420E-9384-80849DF5488AQ36350059-5177D787-EA38-4D41-91D2-83DFAC3515A2Q36350737-143DBB65-042B-4498-9970-E8235A0FC02AQ36408152-9E835E7A-75A1-4C7D-842E-742C344A2CFAQ36655112-2FA99C0A-5DCF-4733-A553-507B00DB1988Q37032505-3EC782C0-F461-4F12-8250-541415C5E8E5Q37084901-46492378-18B3-4A82-A296-B0F8398C1AFFQ37308329-55327E2E-D79F-47F9-AE86-E80526B5795EQ37360059-7C081D9C-0731-427A-B4A0-01DC5DDC23C1Q37381136-7733931B-F3B1-4BEA-9119-2A88EFAEF3DCQ38050028-8ECA3CC8-F876-4AD4-A4F3-56198165664EQ38109907-942526C5-FB14-4292-9B10-02DFF66346F8Q38305482-1F5D4414-B489-4633-9C5D-3C52B1B45E46Q38799466-62A53AFB-F0CF-4709-9115-BEE69A778707Q38843185-69D2CFF0-644E-4DAE-A75B-ECFB2C585C51Q39824832-B86B5CE7-29C9-4FFF-BFF9-9CC94C69B59DQ39967207-5267DD3D-1043-4CC8-9D6D-FF5660822007Q39989919-D7430E43-C66F-4E7F-85BF-2E686C8C572CQ40270472-F794C353-859F-41B0-904D-9DC8D8721FE9Q41153115-3911F3F3-B01A-4D6C-8F4F-2CB1D4F6F14C
P2860
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@ast
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@en
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@nl
type
label
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@ast
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@en
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@nl
prefLabel
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@ast
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@en
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@nl
P2860
P1476
Pain-relieving prospects for adenosine receptors and ectonucleotidases.
@en
P2093
Mark J Zylka
P2860
P304
P356
10.1016/J.MOLMED.2010.12.006
P577
2011-01-13T00:00:00Z